Universitätsklinikum Hamburg Eppendorf
Universitätsklinikum Hamburg Eppendorf
Hamburg, Germany3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients | Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, digestive system disorder, digestive system neoplasm, gastric neoplasm, gastroesophageal adenocarcinoma, neoplasm, stomach disorder | Recruiting | Phase 2 | 2026-06-30 | NCT07176312 | |
| Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer | Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma | Active, not recruiting | Phase 2 | 2026-05-13 | NCT04274426 | |
| Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not applicable | 2024-01-05 | NCT04463641 |